RACHEL TOBLER: Open Payments
NPI 1184065583 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,220 in 120 payments from 12 companies in 2025. Trend: 2023 $1,509 · 2024 $2,193 · 2025 $2,220
Food & beverage: $2,030Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $605 |
| ABBVIE INC. | 34 | $441 |
| Incyte Corporation | 10 | $265 |
| LEO Pharma Inc. | 11 | $194 |
| Galderma Laboratories, L.P. | 10 | $166 |
| GENZYME CORPORATION | 8 | $163 |
| Lilly USA, LLC | 12 | $140 |
| Regeneron Healthcare Solutions, Inc. | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| UCB, Inc. | 2 | $37 |
Products named: TREMFYA, RINVOQ, DUPIXENT, OPZELURA, ADBRY, NEMLUVIO, TALTZ, SKYRIZI.
Industry payments across PA — which companies pay providers there.
